APA (7th ed.) Citation

PY, C., DE, D., HP, H., C, L., JJ, L., HC, K., . . . CP, T. (2009). Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: A prospective post-marketing surveillance study. Clinical drug investigation, 29(11), 729. https://doi.org/10.2165/11315320-000000000-00000

Chicago Style (17th ed.) Citation

PY, Chiu, Dai DE, Hsu HP, Lee C, Lin JJ, Kuo HC, Huang YC, Liu YC, and Tsai CP. "Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease: A Prospective Post-marketing Surveillance Study." Clinical Drug Investigation 29, no. 11 (2009): 729. https://doi.org/10.2165/11315320-000000000-00000.

MLA (9th ed.) Citation

PY, Chiu, et al. "Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease: A Prospective Post-marketing Surveillance Study." Clinical Drug Investigation, vol. 29, no. 11, 2009, p. 729, https://doi.org/10.2165/11315320-000000000-00000.